Human pharmacokinetics and tolerance of oral ganciclovir.
about
Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine; penciclovir]Single-dose pharmacokinetics of valganciclovir in HIV- and CMV-seropositive subjects.Pharmacokinetics of ganciclovir and valganciclovir in the adult horseIn vitro potency of inhibition by antiviral drugs of hematopoietic progenitor colony formation correlates with exposure at hemotoxic levels in human immunodeficiency virus-positive humans.Antiviral therapy: current concepts and practicesThe Effect of Excipients on the Permeability of BCS Class III Compounds and Implications for Biowaivers.Valganciclovir in adult solid organ transplant recipients: pharmacokinetic and pharmacodynamic characteristics and clinical interpretation of plasma concentration measurements.Clinical pharmacokinetics and pharmacodynamics of ganciclovir and valganciclovir in children with cytomegalovirus infection.Pharmacokinetics and absolute bioavailability of oral foscarnet in human immunodeficiency virus-seropositive patients.In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections.Ocular complications of the acquired immunodeficiency syndrome. Focus on the treatment of cytomegalovirus retinitis with ganciclovir and foscarnet.Adverse effects and drug interactions of medications commonly used in the treatment of adult HIV positive patients.Ganciclovir pharmacokinetics and cytokine dynamics in renal transplant recipients with cytomegalovirus infection.Effect of high-dose oral ganciclovir on didanosine disposition in human immunodeficiency virus (HIV)-positive patients.Randomized prospective trial of ganciclovir maintenance therapy for cytomegalovirus retinitis.Effect of food on high-dose oral ganciclovir disposition in HIV-positive subjects.
P2860
Q28354274-8F54F3F3-9D12-469B-9F9F-5F3F200BDA0AQ33144892-B445A525-4845-4CDA-9F37-6FAA64887EA8Q34684840-6D9DE9E1-8543-4270-AE9C-EDF93A45D2FCQ35122740-6EEDBA56-71B0-4C42-8196-8DEA4BBB353CQ36070394-4170DC79-1820-41FE-92FA-E02606BE7976Q36400343-B7336D2E-9DC0-4F51-A997-AB97C3397537Q37570464-F13EC0E5-7F36-4DCB-B1FC-C347E0A2AC02Q38271850-04CF1F22-352A-4775-AE48-7C0D89F61A2FQ39556643-D3388582-E6CA-4FA4-8950-775365BE2413Q40794956-BA65CD18-E9AB-4EE0-850C-95EFB4D7281EQ40853845-E937D7D8-536B-4919-93EB-844B7B7BCED5Q41284012-15D45C14-601E-4A36-A5E0-3B1B6CE61553Q43778417-0BE58FB6-5F22-41D1-86A7-07E0B5F20C75Q45752694-7783CEDE-6B6D-4A7E-8EEF-074DE9F1BC2EQ46215269-9673672D-CFCC-47C6-AC2A-C88863208573Q46433896-8E93EFFE-8AAD-4B2F-9257-83B5137DC461
P2860
Human pharmacokinetics and tolerance of oral ganciclovir.
description
1987 nî lūn-bûn
@nan
1987 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Human pharmacokinetics and tolerance of oral ganciclovir.
@ast
Human pharmacokinetics and tolerance of oral ganciclovir.
@en
type
label
Human pharmacokinetics and tolerance of oral ganciclovir.
@ast
Human pharmacokinetics and tolerance of oral ganciclovir.
@en
prefLabel
Human pharmacokinetics and tolerance of oral ganciclovir.
@ast
Human pharmacokinetics and tolerance of oral ganciclovir.
@en
P2093
P356
P1476
Human pharmacokinetics and tolerance of oral ganciclovir.
@en
P2093
D M Cederberg
H R Brodie
M A Jacobson
P de Miranda
T Burnette
P2860
P304
P356
10.1128/AAC.31.8.1251
P407
P577
1987-08-01T00:00:00Z